

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.49863858 |
| 2 | protein retention in ER lumen (GO:0006621) | 6.03832940 |
| 3 | protein maturation by protein folding (GO:0022417) | 5.74830245 |
| 4 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.55237197 |
| 5 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.18129656 |
| 6 | positive regulation of nuclease activity (GO:0032075) | 5.12763390 |
| 7 | proline biosynthetic process (GO:0006561) | 4.77069793 |
| 8 | * vesicle coating (GO:0006901) | 4.67546344 |
| 9 | regulation of nuclease activity (GO:0032069) | 4.65715821 |
| 10 | COPII vesicle coating (GO:0048208) | 4.61920730 |
| 11 | regulation of early endosome to late endosome transport (GO:2000641) | 4.49290742 |
| 12 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.31925758 |
| 13 | cellular response to unfolded protein (GO:0034620) | 4.12243856 |
| 14 | cellular response to topologically incorrect protein (GO:0035967) | 4.08707619 |
| 15 | protein localization to endosome (GO:0036010) | 3.96916796 |
| 16 | regulation of translational termination (GO:0006449) | 3.94949412 |
| 17 | ER-nucleus signaling pathway (GO:0006984) | 3.93948762 |
| 18 | galactose catabolic process (GO:0019388) | 3.92796292 |
| 19 | nuclear envelope reassembly (GO:0031468) | 3.88709364 |
| 20 | mitotic nuclear envelope reassembly (GO:0007084) | 3.88709364 |
| 21 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.88682992 |
| 22 | NADH metabolic process (GO:0006734) | 3.77488816 |
| 23 | tricarboxylic acid cycle (GO:0006099) | 3.76482933 |
| 24 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.67275153 |
| 25 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.50768556 |
| 26 | glucose 6-phosphate metabolic process (GO:0051156) | 3.44681236 |
| 27 | barbed-end actin filament capping (GO:0051016) | 3.37411665 |
| 28 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.35792456 |
| 29 | oxaloacetate metabolic process (GO:0006107) | 3.35130022 |
| 30 | response to unfolded protein (GO:0006986) | 3.33286734 |
| 31 | response to endoplasmic reticulum stress (GO:0034976) | 3.29543497 |
| 32 | response to topologically incorrect protein (GO:0035966) | 3.28122396 |
| 33 | GDP-mannose metabolic process (GO:0019673) | 3.27006545 |
| 34 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.24482879 |
| 35 | pentose-phosphate shunt (GO:0006098) | 3.20353983 |
| 36 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 3.20129554 |
| 37 | de novo protein folding (GO:0006458) | 3.19792261 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.19001217 |
| 39 | glycolytic process (GO:0006096) | 3.18593768 |
| 40 | proline metabolic process (GO:0006560) | 3.18425285 |
| 41 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.17119602 |
| 42 | signal peptide processing (GO:0006465) | 3.16661467 |
| 43 | peptidyl-asparagine modification (GO:0018196) | 3.16288900 |
| 44 | tricarboxylic acid metabolic process (GO:0072350) | 3.15633723 |
| 45 | negative regulation of microtubule polymerization (GO:0031115) | 3.15535817 |
| 46 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.15467618 |
| 47 | sequestering of metal ion (GO:0051238) | 3.14455526 |
| 48 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.12804368 |
| 49 | positive regulation of lamellipodium assembly (GO:0010592) | 3.09904992 |
| 50 | glucose catabolic process (GO:0006007) | 3.09112773 |
| 51 | virion assembly (GO:0019068) | 3.08262841 |
| 52 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.07964912 |
| 53 | peptidyl-proline hydroxylation (GO:0019511) | 3.07440415 |
| 54 | negative regulation of cell size (GO:0045792) | 3.07386230 |
| 55 | 4-hydroxyproline metabolic process (GO:0019471) | 3.06913118 |
| 56 | amyloid precursor protein catabolic process (GO:0042987) | 3.03025911 |
| 57 | de novo posttranslational protein folding (GO:0051084) | 2.99663820 |
| 58 | monosaccharide biosynthetic process (GO:0046364) | 2.95102235 |
| 59 | protein deneddylation (GO:0000338) | 2.94342861 |
| 60 | regulation of protein heterodimerization activity (GO:0043497) | 2.93440728 |
| 61 | protein hydroxylation (GO:0018126) | 2.93096469 |
| 62 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.92858776 |
| 63 | membrane budding (GO:0006900) | 2.92710216 |
| 64 | localization within membrane (GO:0051668) | 2.89798038 |
| 65 | regulation of translational fidelity (GO:0006450) | 2.88168089 |
| 66 | growth hormone secretion (GO:0030252) | 2.85168354 |
| 67 | L-serine transport (GO:0015825) | 2.83929314 |
| 68 | protein N-linked glycosylation (GO:0006487) | 2.82839160 |
| 69 | protein insertion into membrane (GO:0051205) | 2.82695564 |
| 70 | positive regulation of lamellipodium organization (GO:1902745) | 2.80876393 |
| 71 | hexose biosynthetic process (GO:0019319) | 2.80651664 |
| 72 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.80360831 |
| 73 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.78039770 |
| 74 | serine transport (GO:0032329) | 2.77625279 |
| 75 | chaperone-mediated protein folding (GO:0061077) | 2.76729582 |
| 76 | NADPH regeneration (GO:0006740) | 2.74344347 |
| 77 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.74300420 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73999375 |
| 79 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.73717098 |
| 80 | exocrine pancreas development (GO:0031017) | 2.72853352 |
| 81 | actin filament depolymerization (GO:0030042) | 2.72657235 |
| 82 | cullin deneddylation (GO:0010388) | 2.72531145 |
| 83 | maternal placenta development (GO:0001893) | 2.72518198 |
| 84 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.72241651 |
| 85 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.71192605 |
| 86 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.70663136 |
| 87 | positive regulation of pseudopodium assembly (GO:0031274) | 2.69517719 |
| 88 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.68797027 |
| 89 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.68506854 |
| 90 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.66583991 |
| 91 | actin nucleation (GO:0045010) | 2.64747627 |
| 92 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.62663482 |
| 93 | amyloid precursor protein metabolic process (GO:0042982) | 2.62553814 |
| 94 | mitochondrial calcium ion transport (GO:0006851) | 2.62458570 |
| 95 | cerebellar Purkinje cell layer development (GO:0021680) | 2.61690829 |
| 96 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60490497 |
| 97 | regulation of proton transport (GO:0010155) | 2.58643208 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.58259468 |
| 99 | endothelial tube morphogenesis (GO:0061154) | 2.57755336 |
| 100 | morphogenesis of an endothelium (GO:0003159) | 2.57755336 |
| 101 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.57698395 |
| 102 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.54784152 |
| 103 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.53102695 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 2.51571969 |
| 105 | peptide catabolic process (GO:0043171) | 2.51557417 |
| 106 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51464093 |
| 107 | peptide hormone processing (GO:0016486) | 2.51261015 |
| 108 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.50990553 |
| 109 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.50990553 |
| 110 | pinocytosis (GO:0006907) | 2.50318945 |
| 111 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50039687 |
| 112 | pentose metabolic process (GO:0019321) | 2.49765273 |
| 113 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.49666890 |
| 114 | stress fiber assembly (GO:0043149) | 2.49467954 |
| 115 | glycosphingolipid catabolic process (GO:0046479) | 2.49135673 |
| 116 | platelet aggregation (GO:0070527) | 2.48238881 |
| 117 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.46763998 |
| 118 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.46753458 |
| 119 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.46606377 |
| 120 | nucleobase biosynthetic process (GO:0046112) | 2.46069334 |
| 121 | * antigen processing and presentation of exogenous antigen (GO:0019884) | 2.45101221 |
| 122 | Golgi organization (GO:0007030) | 2.45028746 |
| 123 | * antigen processing and presentation of exogenous peptide antigen (GO:0002478) | 2.43967914 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.43889715 |
| 125 | response to misfolded protein (GO:0051788) | 2.42910817 |
| 126 | gluconeogenesis (GO:0006094) | 2.42210480 |
| 127 | regulation of metalloenzyme activity (GO:0048552) | 2.41828701 |
| 128 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.41505283 |
| 129 | * antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 2.40742309 |
| 130 | peptidyl-arginine N-methylation (GO:0035246) | 2.40244452 |
| 131 | peptidyl-arginine methylation (GO:0018216) | 2.40244452 |
| 132 | purine nucleotide salvage (GO:0032261) | 2.40162872 |
| 133 | prostanoid biosynthetic process (GO:0046457) | 2.39909517 |
| 134 | prostaglandin biosynthetic process (GO:0001516) | 2.39909517 |
| 135 | protein autoprocessing (GO:0016540) | 2.39585802 |
| 136 | viral protein processing (GO:0019082) | 2.38529257 |
| 137 | basement membrane organization (GO:0071711) | 2.35430481 |
| 138 | pyrimidine-containing compound salvage (GO:0008655) | 2.33370840 |
| 139 | pyrimidine nucleoside salvage (GO:0043097) | 2.33370840 |
| 140 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.33080567 |
| 141 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.33080567 |
| 142 | glycolipid catabolic process (GO:0019377) | 2.31575496 |
| 143 | maintenance of protein localization in organelle (GO:0072595) | 2.31415728 |
| 144 | protein targeting to plasma membrane (GO:0072661) | 2.31180974 |
| 145 | activation of Rac GTPase activity (GO:0032863) | 2.30206066 |
| 146 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.29742946 |
| 147 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.29404673 |
| 148 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.29404673 |
| 149 | regulation of superoxide anion generation (GO:0032928) | 2.28873185 |
| 150 | positive regulation of receptor recycling (GO:0001921) | 2.28713108 |
| 151 | * regulation of defense response to virus by virus (GO:0050690) | 2.28246814 |
| 152 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.27188194 |
| 153 | regulation of pseudopodium assembly (GO:0031272) | 2.26747556 |
| 154 | transferrin transport (GO:0033572) | 2.26732111 |
| 155 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.25659742 |
| 156 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.24266403 |
| 157 | NIK/NF-kappaB signaling (GO:0038061) | 2.24078228 |
| 158 | adherens junction assembly (GO:0034333) | 2.24020914 |
| 159 | desmosome organization (GO:0002934) | 2.22502876 |
| 160 | * Golgi transport vesicle coating (GO:0048200) | 10.4719191 |
| 161 | * COPI coating of Golgi vesicle (GO:0048205) | 10.4719191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.34553467 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.50117596 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.69602791 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68590688 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.65114540 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62107955 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.40105310 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27152455 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.10689340 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.04888205 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04111500 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.01576858 |
| 13 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.99688704 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98855779 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.97387823 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88685985 |
| 17 | ATF3_27146783_Chip-Seq_COLON_Human | 1.87514362 |
| 18 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.86364735 |
| 19 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.86234382 |
| 20 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.86092876 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.83314777 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79620135 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79034231 |
| 24 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78656161 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.77076361 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76584348 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75695582 |
| 28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.74567230 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.74427520 |
| 30 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71241216 |
| 31 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71234286 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67723333 |
| 33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66739629 |
| 34 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66257746 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63157262 |
| 36 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.62025509 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60439453 |
| 38 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58638304 |
| 39 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.58607436 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.58094627 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57763954 |
| 42 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.53966203 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50648494 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50031833 |
| 45 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.47380347 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46972293 |
| 47 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44985305 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44849133 |
| 49 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.42101917 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41781286 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41181799 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41179156 |
| 53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39580908 |
| 54 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39007453 |
| 55 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38537962 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37941300 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36766311 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34715054 |
| 59 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.34574242 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34093403 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33759063 |
| 62 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33023392 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32932530 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30984079 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30123886 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29080793 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28824279 |
| 68 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28469701 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28420003 |
| 70 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27931210 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26709801 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26450079 |
| 73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.26291591 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24536542 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24169865 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.22995668 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22332329 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20501410 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20213609 |
| 80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19761344 |
| 81 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19147118 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18694033 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18558971 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17699885 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17656943 |
| 86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17654612 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17454725 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14889412 |
| 89 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14882177 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14836477 |
| 91 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.14719391 |
| 92 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14281632 |
| 93 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12951918 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12518092 |
| 95 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12368791 |
| 96 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12078119 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10202000 |
| 98 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09889384 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09317215 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09113563 |
| 101 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09026928 |
| 102 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.08727041 |
| 103 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07728521 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06683731 |
| 105 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06502548 |
| 106 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06299995 |
| 107 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06156917 |
| 108 | * MAF_26560356_Chip-Seq_TH1_Human | 1.05884822 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03431779 |
| 110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02550141 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02530524 |
| 112 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01531491 |
| 113 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01279537 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01011458 |
| 115 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.00901049 |
| 116 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00643418 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00299327 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00145523 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99830519 |
| 120 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99827412 |
| 121 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99508161 |
| 122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99047638 |
| 123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98870717 |
| 124 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98652432 |
| 125 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97974647 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97834761 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97542785 |
| 128 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96942629 |
| 129 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96797025 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96793286 |
| 131 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96783284 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96351496 |
| 133 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95354991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 3.69316825 |
| 2 | MP0005451_abnormal_body_composition | 3.47367291 |
| 3 | MP0008260_abnormal_autophagy | 3.41834344 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.29156878 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.23993493 |
| 6 | MP0000013_abnormal_adipose_tissue | 3.09485161 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 3.06299213 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.96200202 |
| 9 | MP0003123_paternal_imprinting | 2.91672243 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.86029547 |
| 11 | MP0003283_abnormal_digestive_organ | 2.77115876 |
| 12 | MP0003693_abnormal_embryo_hatching | 2.76018854 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.74618322 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.71807148 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.39400015 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.27255107 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.26168496 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.17512424 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.13030068 |
| 20 | MP0004233_abnormal_muscle_weight | 1.97092074 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.95303979 |
| 22 | MP0003436_decreased_susceptibility_to | 1.89403312 |
| 23 | MP0005501_abnormal_skin_physiology | 1.89366044 |
| 24 | MP0003122_maternal_imprinting | 1.88341186 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.83782158 |
| 26 | MP0002796_impaired_skin_barrier | 1.83086428 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.79301526 |
| 28 | MP0001944_abnormal_pancreas_morphology | 1.76025950 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.69961066 |
| 30 | MP0009840_abnormal_foam_cell | 1.69614137 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.66781399 |
| 32 | MP0001849_ear_inflammation | 1.61557750 |
| 33 | MP0001730_embryonic_growth_arrest | 1.61205882 |
| 34 | MP0000003_abnormal_adipose_tissue | 1.60850416 |
| 35 | MP0009278_abnormal_bone_marrow | 1.59059369 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.57980889 |
| 37 | MP0002693_abnormal_pancreas_physiology | 1.55846810 |
| 38 | MP0000537_abnormal_urethra_morphology | 1.54362780 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.52600488 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.50875392 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.47057318 |
| 42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44666748 |
| 43 | MP0000358_abnormal_cell_content/ | 1.44070037 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.43146515 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.41412249 |
| 46 | MP0005083_abnormal_biliary_tract | 1.37723827 |
| 47 | MP0004272_abnormal_basement_membrane | 1.35580829 |
| 48 | MP0002896_abnormal_bone_mineralization | 1.35531662 |
| 49 | MP0004510_myositis | 1.35384267 |
| 50 | MP0004858_abnormal_nervous_system | 1.34518347 |
| 51 | MP0001756_abnormal_urination | 1.33348785 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.31378326 |
| 53 | MP0004043_abnormal_pH_regulation | 1.31228612 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.30502496 |
| 55 | MP0005623_abnormal_meninges_morphology | 1.30128774 |
| 56 | MP0003119_abnormal_digestive_system | 1.27287293 |
| 57 | MP0005023_abnormal_wound_healing | 1.26916531 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.25214279 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.22437285 |
| 60 | MP0004859_abnormal_synaptic_plasticity | 1.21545922 |
| 61 | MP0002060_abnormal_skin_morphology | 1.21332902 |
| 62 | MP0002653_abnormal_ependyma_morphology | 1.21198047 |
| 63 | MP0003329_amyloid_beta_deposits | 1.20234158 |
| 64 | MP0003075_altered_response_to | 1.19306344 |
| 65 | MP0005165_increased_susceptibility_to | 1.18509266 |
| 66 | MP0001697_abnormal_embryo_size | 1.16745648 |
| 67 | MP0000681_abnormal_thyroid_gland | 1.15798223 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.15247760 |
| 69 | MP0002080_prenatal_lethality | 1.14890040 |
| 70 | MP0000858_altered_metastatic_potential | 1.14690911 |
| 71 | MP0005257_abnormal_intraocular_pressure | 1.14046871 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.12665397 |
| 73 | MP0002269_muscular_atrophy | 1.12562833 |
| 74 | MP0005275_abnormal_skin_tensile | 1.12388967 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.11990025 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.11791856 |
| 77 | MP0003303_peritoneal_inflammation | 1.10860352 |
| 78 | MP0001765_abnormal_ion_homeostasis | 1.05705597 |
| 79 | MP0005187_abnormal_penis_morphology | 1.05413876 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.04185427 |
| 81 | MP0002132_abnormal_respiratory_system | 0.99166692 |
| 82 | MP0000350_abnormal_cell_proliferation | 0.98874243 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.98364655 |
| 84 | MP0009931_abnormal_skin_appearance | 0.98096211 |
| 85 | MP0003186_abnormal_redox_activity | 0.97497453 |
| 86 | MP0001881_abnormal_mammary_gland | 0.92178906 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.91656258 |
| 88 | MP0003866_abnormal_defecation | 0.90807695 |
| 89 | MP0003077_abnormal_cell_cycle | 0.90454079 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.89623724 |
| 91 | MP0005384_cellular_phenotype | 0.88191020 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.88169424 |
| 93 | MP0001243_abnormal_dermal_layer | 0.87976526 |
| 94 | MP0001958_emphysema | 0.87624113 |
| 95 | MP0003984_embryonic_growth_retardation | 0.87548041 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.87316773 |
| 97 | MP0010307_abnormal_tumor_latency | 0.87035967 |
| 98 | MP0005621_abnormal_cell_physiology | 0.86846822 |
| 99 | MP0001853_heart_inflammation | 0.86072625 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.85424008 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.85424008 |
| 102 | MP0000534_abnormal_ureter_morphology | 0.84682989 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.83784609 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.83296727 |
| 105 | MP0000313_abnormal_cell_death | 0.83010725 |
| 106 | MP0008874_decreased_physiological_sensi | 0.82158755 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.81995402 |
| 108 | MP0000490_abnormal_crypts_of | 0.81338355 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.80636541 |
| 110 | MP0002084_abnormal_developmental_patter | 0.79768601 |
| 111 | MP0000343_altered_response_to | 0.79111051 |
| 112 | MP0002098_abnormal_vibrissa_morphology | 0.78762327 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.77027924 |
| 114 | MP0003091_abnormal_cell_migration | 0.76733915 |
| 115 | MP0008004_abnormal_stomach_pH | 0.76019081 |
| 116 | MP0004197_abnormal_fetal_growth/weight/ | 0.75754540 |
| 117 | MP0005166_decreased_susceptibility_to | 0.75744832 |
| 118 | MP0005380_embryogenesis_phenotype | 0.74749051 |
| 119 | MP0001672_abnormal_embryogenesis/_devel | 0.74749051 |
| 120 | MP0005025_abnormal_response_to | 0.74312255 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.74151306 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.73262286 |
| 123 | MP0003724_increased_susceptibility_to | 0.72706030 |
| 124 | MP0003111_abnormal_nucleus_morphology | 0.72673342 |
| 125 | MP0000467_abnormal_esophagus_morphology | 0.72669736 |
| 126 | MP0003828_pulmonary_edema | 0.72307783 |
| 127 | MP0002085_abnormal_embryonic_tissue | 0.71754754 |
| 128 | MP0010771_integument_phenotype | 0.71018337 |
| 129 | MP0002419_abnormal_innate_immunity | 0.70980634 |
| 130 | MP0003279_aneurysm | 0.70612457 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.69890366 |
| 132 | MP0005409_darkened_coat_color | 0.69791460 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.69664704 |
| 134 | MP0009053_abnormal_anal_canal | 0.69028783 |
| 135 | MP0003795_abnormal_bone_structure | 0.68111522 |
| 136 | MP0000751_myopathy | 0.67190805 |
| 137 | MP0003448_altered_tumor_morphology | 0.67150444 |
| 138 | MP0008932_abnormal_embryonic_tissue | 0.66990408 |
| 139 | MP0002970_abnormal_white_adipose | 0.66726522 |
| 140 | MP0009672_abnormal_birth_weight | 0.66665249 |
| 141 | MP0009333_abnormal_splenocyte_physiolog | 0.66557721 |
| 142 | MP0001915_intracranial_hemorrhage | 0.66069862 |
| 143 | MP0000747_muscle_weakness | 0.65964534 |
| 144 | MP0004808_abnormal_hematopoietic_stem | 0.65826302 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.64720739 |
| 146 | MP0000462_abnormal_digestive_system | 0.64578793 |
| 147 | MP0004087_abnormal_muscle_fiber | 0.63106648 |
| 148 | MP0004947_skin_inflammation | 0.62949142 |
| 149 | MP0000604_amyloidosis | 0.62933241 |
| 150 | MP0003121_genomic_imprinting | 0.62822110 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.62592395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal gallbladder physiology (HP:0012438) | 4.99396231 |
| 2 | Cholecystitis (HP:0001082) | 4.99396231 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.33025813 |
| 4 | Distal lower limb amyotrophy (HP:0008944) | 3.25077633 |
| 5 | Abnormality of the anterior horn cell (HP:0006802) | 3.23176040 |
| 6 | Degeneration of anterior horn cells (HP:0002398) | 3.23176040 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.07770115 |
| 8 | Upper limb muscle weakness (HP:0003484) | 3.06202176 |
| 9 | Petechiae (HP:0000967) | 3.03244080 |
| 10 | Hand muscle atrophy (HP:0009130) | 2.99616612 |
| 11 | Hypercortisolism (HP:0001578) | 2.97828540 |
| 12 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91578598 |
| 13 | Hypoglycemic coma (HP:0001325) | 2.89805815 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 2.86626105 |
| 15 | Hyperacusis (HP:0010780) | 2.84916471 |
| 16 | Limb-girdle muscle atrophy (HP:0003797) | 2.72518855 |
| 17 | Cervical subluxation (HP:0003308) | 2.71514328 |
| 18 | Ragged-red muscle fibers (HP:0003200) | 2.70903297 |
| 19 | Achilles tendon contracture (HP:0001771) | 2.69136232 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.65603735 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65603735 |
| 22 | Shoulder girdle muscle weakness (HP:0003547) | 2.61313479 |
| 23 | Neoplasm of the adrenal gland (HP:0100631) | 2.60632934 |
| 24 | Cholelithiasis (HP:0001081) | 2.55917680 |
| 25 | Pheochromocytoma (HP:0002666) | 2.54960367 |
| 26 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.52125289 |
| 27 | Abnormality of the Achilles tendon (HP:0005109) | 2.52087375 |
| 28 | Upper limb amyotrophy (HP:0009129) | 2.51209802 |
| 29 | Distal upper limb amyotrophy (HP:0007149) | 2.51209802 |
| 30 | Striae distensae (HP:0001065) | 2.50020852 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.49267274 |
| 32 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.46588622 |
| 33 | Angiofibromas (HP:0010615) | 2.46263065 |
| 34 | Adenoma sebaceum (HP:0009720) | 2.46263065 |
| 35 | Neuroendocrine neoplasm (HP:0100634) | 2.44832863 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.44453975 |
| 37 | Growth hormone excess (HP:0000845) | 2.43727050 |
| 38 | Long toe (HP:0010511) | 2.43711391 |
| 39 | Pelvic girdle muscle weakness (HP:0003749) | 2.43473819 |
| 40 | Late onset (HP:0003584) | 2.43154599 |
| 41 | Purpura (HP:0000979) | 2.40350323 |
| 42 | Loss of speech (HP:0002371) | 2.39899635 |
| 43 | Aortic aneurysm (HP:0004942) | 2.39169495 |
| 44 | Conjunctival hamartoma (HP:0100780) | 2.37235982 |
| 45 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.34867221 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.34254265 |
| 47 | Abnormality of glycolysis (HP:0004366) | 2.34229755 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.33953564 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33328193 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33328193 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33328193 |
| 52 | Insomnia (HP:0100785) | 2.31352599 |
| 53 | Lower limb amyotrophy (HP:0007210) | 2.29706194 |
| 54 | Menorrhagia (HP:0000132) | 2.27333897 |
| 55 | Abnormal pancreas size (HP:0012094) | 2.27282194 |
| 56 | Gout (HP:0001997) | 2.27263870 |
| 57 | Dilatation of the ascending aorta (HP:0005111) | 2.26809899 |
| 58 | Hypokinesia (HP:0002375) | 2.26125373 |
| 59 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.25799886 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.23490463 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23262867 |
| 62 | Ketoacidosis (HP:0001993) | 2.22269785 |
| 63 | Reticulocytosis (HP:0001923) | 2.22196971 |
| 64 | Increased connective tissue (HP:0009025) | 2.22016520 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.21454310 |
| 66 | Hypoplasia of the pons (HP:0012110) | 2.21416455 |
| 67 | Hypertensive crisis (HP:0100735) | 2.18502248 |
| 68 | Aneurysm (HP:0002617) | 2.18353524 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.17034525 |
| 70 | Palpitations (HP:0001962) | 2.16231999 |
| 71 | Multiple enchondromatosis (HP:0005701) | 2.12522160 |
| 72 | Abnormality of the gallbladder (HP:0005264) | 2.10999032 |
| 73 | Difficulty climbing stairs (HP:0003551) | 2.08256266 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.07356792 |
| 75 | Ankle contracture (HP:0006466) | 2.07122455 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.05580047 |
| 77 | Enlarged penis (HP:0000040) | 2.05575461 |
| 78 | Diminished motivation (HP:0000745) | 2.05250557 |
| 79 | Fasciculations (HP:0002380) | 2.04961534 |
| 80 | Myopathic facies (HP:0002058) | 2.03310452 |
| 81 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.02511758 |
| 82 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.02511758 |
| 83 | Deep palmar crease (HP:0006191) | 2.01453073 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.01030633 |
| 85 | Long palpebral fissure (HP:0000637) | 2.00401050 |
| 86 | Increased mean platelet volume (HP:0011877) | 1.97900736 |
| 87 | Shallow orbits (HP:0000586) | 1.97321308 |
| 88 | Hyperglycemia (HP:0003074) | 1.96831474 |
| 89 | Truncus arteriosus (HP:0001660) | 1.96675348 |
| 90 | Abnormal neuron morphology (HP:0012757) | 1.95365053 |
| 91 | Abnormality of the motor neurons (HP:0002450) | 1.95365053 |
| 92 | Trismus (HP:0000211) | 1.94814542 |
| 93 | Micronodular cirrhosis (HP:0001413) | 1.94770945 |
| 94 | Severe short stature (HP:0003510) | 1.94503977 |
| 95 | Spinal canal stenosis (HP:0003416) | 1.92611026 |
| 96 | Abnormality of the umbilical cord (HP:0010881) | 1.92575316 |
| 97 | Apathy (HP:0000741) | 1.92458301 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.92368008 |
| 99 | Hyperparathyroidism (HP:0000843) | 1.88900757 |
| 100 | Osteopenia (HP:0000938) | 1.88851775 |
| 101 | Visual hallucinations (HP:0002367) | 1.86622757 |
| 102 | Impaired platelet aggregation (HP:0003540) | 1.85679825 |
| 103 | Abnormal platelet function (HP:0011869) | 1.85679825 |
| 104 | Aortic dissection (HP:0002647) | 1.84520233 |
| 105 | Insulin resistance (HP:0000855) | 1.84399367 |
| 106 | Back pain (HP:0003418) | 1.84190277 |
| 107 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84184531 |
| 108 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84006602 |
| 109 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84006602 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 1.83763572 |
| 111 | Athetosis (HP:0002305) | 1.83474475 |
| 112 | Spinal rigidity (HP:0003306) | 1.83461635 |
| 113 | Agitation (HP:0000713) | 1.83165255 |
| 114 | Intestinal polyposis (HP:0200008) | 1.82692061 |
| 115 | Hepatosplenomegaly (HP:0001433) | 1.82583685 |
| 116 | Microretrognathia (HP:0000308) | 1.82211032 |
| 117 | Axonal loss (HP:0003447) | 1.82109758 |
| 118 | Spinal muscular atrophy (HP:0007269) | 1.82094777 |
| 119 | Unilateral renal agenesis (HP:0000122) | 1.81685904 |
| 120 | Fatigue (HP:0012378) | 1.81145999 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.81110416 |
| 122 | Distal sensory impairment (HP:0002936) | 1.80434813 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.80411694 |
| 124 | Prominent metopic ridge (HP:0005487) | 1.80208415 |
| 125 | Polycythemia (HP:0001901) | 1.79023970 |
| 126 | Hydroureter (HP:0000072) | 1.78314693 |
| 127 | Thin bony cortex (HP:0002753) | 1.78103474 |
| 128 | Atelectasis (HP:0100750) | 1.78065843 |
| 129 | Rough bone trabeculation (HP:0100670) | 1.77190596 |
| 130 | Slender long bone (HP:0003100) | 1.76547059 |
| 131 | Thoracolumbar scoliosis (HP:0002944) | 1.74964565 |
| 132 | Postnatal microcephaly (HP:0005484) | 1.74360756 |
| 133 | Orthostatic hypotension (HP:0001278) | 1.73817528 |
| 134 | Intestinal polyp (HP:0005266) | 1.73664944 |
| 135 | Stridor (HP:0010307) | 1.71877005 |
| 136 | Hyperthyroidism (HP:0000836) | 1.71422690 |
| 137 | Ulnar deviation of the wrist (HP:0003049) | 1.71175540 |
| 138 | Poor head control (HP:0002421) | 1.71155395 |
| 139 | Resting tremor (HP:0002322) | 1.71061513 |
| 140 | Hammertoe (HP:0001765) | 1.71058083 |
| 141 | Seborrheic dermatitis (HP:0001051) | 1.70142574 |
| 142 | Nuclear cataract (HP:0100018) | 1.69802880 |
| 143 | Joint stiffness (HP:0001387) | 1.69660116 |
| 144 | Increased density of long bones (HP:0006392) | 1.69148670 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67729956 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67729956 |
| 147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67729956 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.67159933 |
| 149 | Adrenal overactivity (HP:0002717) | 1.66775021 |
| 150 | Hyperactive renin-angiotensin system (HP:0000841) | 1.66180306 |
| 151 | Cerebral inclusion bodies (HP:0100314) | 1.66131681 |
| 152 | Peritonitis (HP:0002586) | 1.65588294 |
| 153 | Beaking of vertebral bodies (HP:0004568) | 1.65473612 |
| 154 | Prolonged bleeding time (HP:0003010) | 1.64940021 |
| 155 | Symptomatic seizures (HP:0011145) | 1.64797923 |
| 156 | Polygenic inheritance (HP:0010982) | 1.64622557 |
| 157 | Tongue fasciculations (HP:0001308) | 1.64548356 |
| 158 | Progressive neurologic deterioration (HP:0002344) | 1.64511535 |
| 159 | Gastrointestinal dysmotility (HP:0002579) | 1.64474367 |
| 160 | Bone pain (HP:0002653) | 1.64132415 |
| 161 | Sparse lateral eyebrow (HP:0005338) | 1.63346801 |
| 162 | Hemorrhage of the eye (HP:0011885) | 1.62029169 |
| 163 | Broad face (HP:0000283) | 1.61654974 |
| 164 | Ankle clonus (HP:0011448) | 1.61586254 |
| 165 | Tetraparesis (HP:0002273) | 1.61468521 |
| 166 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61434656 |
| 167 | Single umbilical artery (HP:0001195) | 1.60617945 |
| 168 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.60617945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.15676260 |
| 2 | TESK1 | 3.57155613 |
| 3 | NEK1 | 3.14547467 |
| 4 | IRAK3 | 3.01593157 |
| 5 | ERN1 | 2.95676569 |
| 6 | SCYL2 | 2.92375840 |
| 7 | KSR2 | 2.91670289 |
| 8 | PKN2 | 2.82201754 |
| 9 | PRPF4B | 2.61708164 |
| 10 | PASK | 2.52576458 |
| 11 | TESK2 | 2.15174283 |
| 12 | SIK3 | 2.10045840 |
| 13 | ARAF | 2.06474989 |
| 14 | LIMK1 | 2.06108493 |
| 15 | SMG1 | 2.03751378 |
| 16 | EPHA2 | 1.91294270 |
| 17 | EEF2K | 1.86507511 |
| 18 | BUB1 | 1.78041685 |
| 19 | MAP3K9 | 1.77789028 |
| 20 | ICK | 1.77530850 |
| 21 | PAK4 | 1.76893339 |
| 22 | TAOK1 | 1.63152164 |
| 23 | MAP3K2 | 1.59798629 |
| 24 | MAP3K11 | 1.59379367 |
| 25 | SIK1 | 1.56711202 |
| 26 | MAP3K12 | 1.55034534 |
| 27 | PRKD3 | 1.54586041 |
| 28 | TSSK6 | 1.54476062 |
| 29 | LRRK2 | 1.53857937 |
| 30 | MAPKAPK3 | 1.51864788 |
| 31 | EPHB1 | 1.49309768 |
| 32 | KSR1 | 1.40009943 |
| 33 | RAF1 | 1.39689741 |
| 34 | FLT3 | 1.38928691 |
| 35 | DAPK1 | 1.37397164 |
| 36 | MST1R | 1.35984748 |
| 37 | KDR | 1.32434940 |
| 38 | RPS6KA4 | 1.28946466 |
| 39 | CDK12 | 1.26488230 |
| 40 | FER | 1.25469007 |
| 41 | BRAF | 1.24540603 |
| 42 | PTK2 | 1.20310298 |
| 43 | ILK | 1.18191763 |
| 44 | EIF2AK1 | 1.18185987 |
| 45 | MAP3K3 | 1.17959813 |
| 46 | RIPK1 | 1.17429067 |
| 47 | MAP3K1 | 1.16589729 |
| 48 | PTK6 | 1.13329688 |
| 49 | MAP3K10 | 1.12052403 |
| 50 | MAP2K1 | 1.11779528 |
| 51 | CCNB1 | 1.11132356 |
| 52 | LATS2 | 1.06369531 |
| 53 | TGFBR1 | 1.05662921 |
| 54 | MINK1 | 1.01598352 |
| 55 | MAP3K8 | 1.01037455 |
| 56 | BRSK1 | 0.94937509 |
| 57 | CAMKK1 | 0.94075003 |
| 58 | BMX | 0.91163196 |
| 59 | RIPK4 | 0.90982139 |
| 60 | ZAP70 | 0.88144765 |
| 61 | MOS | 0.87565634 |
| 62 | PDGFRA | 0.87264604 |
| 63 | MAP2K3 | 0.86732906 |
| 64 | WEE1 | 0.86684508 |
| 65 | TTN | 0.85759459 |
| 66 | LMTK2 | 0.83786547 |
| 67 | PAK3 | 0.83396237 |
| 68 | BRSK2 | 0.77869887 |
| 69 | MYLK | 0.76968580 |
| 70 | NTRK1 | 0.76101849 |
| 71 | PRKD2 | 0.75478922 |
| 72 | CAMKK2 | 0.74423872 |
| 73 | EPHA3 | 0.73635743 |
| 74 | PAK1 | 0.73155347 |
| 75 | PDK2 | 0.72134405 |
| 76 | MAP2K2 | 0.69587813 |
| 77 | RET | 0.69285078 |
| 78 | RPS6KB2 | 0.67978228 |
| 79 | CDK14 | 0.67946835 |
| 80 | PDPK1 | 0.67891181 |
| 81 | STK10 | 0.67073775 |
| 82 | FGFR4 | 0.66683166 |
| 83 | ABL2 | 0.65626564 |
| 84 | NME1 | 0.65289692 |
| 85 | NEK2 | 0.64023960 |
| 86 | PIM2 | 0.62102965 |
| 87 | BCKDK | 0.61112722 |
| 88 | STK38 | 0.59856251 |
| 89 | IRAK2 | 0.58332385 |
| 90 | TAOK2 | 0.57706635 |
| 91 | MST4 | 0.57609140 |
| 92 | AKT2 | 0.55375387 |
| 93 | PRKCI | 0.55156557 |
| 94 | PTK2B | 0.55146041 |
| 95 | CDK18 | 0.54698367 |
| 96 | MAP3K5 | 0.54542361 |
| 97 | MTOR | 0.54353521 |
| 98 | MAP3K13 | 0.53825903 |
| 99 | EIF2AK3 | 0.53269244 |
| 100 | CDK15 | 0.52310605 |
| 101 | MAP3K6 | 0.52078889 |
| 102 | CLK1 | 0.50956268 |
| 103 | DAPK2 | 0.49925180 |
| 104 | PAK6 | 0.49421689 |
| 105 | VRK2 | 0.48814032 |
| 106 | PLK2 | 0.48709051 |
| 107 | MAP3K14 | 0.48704437 |
| 108 | PAK2 | 0.48348580 |
| 109 | CDK11A | 0.47958434 |
| 110 | CDK7 | 0.47845548 |
| 111 | NTRK3 | 0.47594423 |
| 112 | NME2 | 0.46902920 |
| 113 | ALK | 0.46395235 |
| 114 | FRK | 0.45949404 |
| 115 | GRK6 | 0.45210702 |
| 116 | CSNK1G3 | 0.43913372 |
| 117 | DAPK3 | 0.43053702 |
| 118 | FGFR1 | 0.42933350 |
| 119 | TRIM28 | 0.42584481 |
| 120 | AURKA | 0.42535526 |
| 121 | CDK19 | 0.41417366 |
| 122 | CDC7 | 0.40814291 |
| 123 | ERBB3 | 0.40708330 |
| 124 | MET | 0.40561551 |
| 125 | PDK3 | 0.40026888 |
| 126 | PDK4 | 0.40026888 |
| 127 | MAPKAPK2 | 0.39405341 |
| 128 | MARK2 | 0.38916455 |
| 129 | TBK1 | 0.37879285 |
| 130 | NEK9 | 0.37483733 |
| 131 | DDR2 | 0.36396386 |
| 132 | HIPK2 | 0.34778070 |
| 133 | PRKG2 | 0.34567397 |
| 134 | MAPK11 | 0.34544696 |
| 135 | PRKD1 | 0.34399205 |
| 136 | CDC42BPA | 0.33964555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.36981994 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.93963330 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.92418678 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.59043064 |
| 5 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.54894984 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.40464851 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.38264835 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29813018 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.15334566 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.06095977 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92762271 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87983006 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.85010404 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74758877 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73985254 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.73196075 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.62725939 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56279634 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.54248404 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.53531586 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.41321486 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38345702 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33071712 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32147483 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30147563 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27574737 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.25370649 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24889180 |
| 29 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.20781328 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18530325 |
| 31 | * Legionellosis_Homo sapiens_hsa05134 | 1.16651656 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.16092051 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.12904021 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11088982 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.10418163 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.08656249 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.06000656 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02839072 |
| 39 | DNA replication_Homo sapiens_hsa03030 | 1.01662809 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01164518 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99849450 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97228309 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 0.95781892 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 0.93730506 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92862057 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91658354 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88451151 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88154564 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86920703 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86687711 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.85755230 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85672224 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84888430 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84798734 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.84753624 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82231385 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81913364 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80336870 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80255733 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79469385 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78698637 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78675623 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.78305646 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77421965 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76489237 |
| 66 | * Endocytosis_Homo sapiens_hsa04144 | 0.76240183 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75794463 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74833301 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73708089 |
| 70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72903954 |
| 71 | Gap junction_Homo sapiens_hsa04540 | 0.72808777 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72456338 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.71660897 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70608683 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69328844 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.69066873 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67415994 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66747512 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66643033 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.66370872 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65235333 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64484037 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64410716 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62427619 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62014336 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60490059 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60388357 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59777822 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58814373 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58252278 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56771697 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56722816 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55836561 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.55432941 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.55274196 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54773092 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54427100 |
| 98 | Base excision repair_Homo sapiens_hsa03410 | 0.53833064 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52999985 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.52722994 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52434802 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52323394 |
| 103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52273179 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.52269474 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51892298 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51725131 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51144328 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50931840 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50715556 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50506906 |
| 111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50440978 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49927110 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.49342058 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49143575 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47422688 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46468335 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45806703 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45647597 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.45611423 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45183682 |
| 121 | Spliceosome_Homo sapiens_hsa03040 | 0.44377647 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.43597314 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42900857 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42459963 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41974353 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40368472 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.39836327 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39414473 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38181693 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.36700749 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35000401 |
| 132 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34079981 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32719709 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32683720 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29846211 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29672970 |

